About Sanofi-Aventis
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Sanofi-Aventis
During the past decade, Sanofi-Aventis conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse
2003-04-01
Unknown status
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
2006-10-01
2011-04-01
Completed
349
Multicenter Trial to Treat Patients With Relapsed/Refractory Aggressive Non Hodgkin Lymphoma
2004-12-01
2010-06-01
Completed
67
A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy
2011-04-04
2014-03-28
Terminated
338
A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer
2015-01-20
2020-08-14
Completed
645
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
2017-02-03
2019-12-26
Completed
326
A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma
2017-10-04
2025-04-23
Recruiting
336
ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19
2020-11-03
2021-05-31
Terminated
133
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Sanofi-Aventis"
#1 collaborator was "Cancer International Research Group (CIRG)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Sanofi-Aventis
According to Clinical.Site data, the most researched conditions in "Sanofi-Aventis" are
"Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Sanofi-Aventis" in a lesser frequency.
Clinical Trials Intervention Types at Sanofi-Aventis
Most popular intervention types in "Sanofi-Aventis" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Docetaxel,doxorubicin, cyclophosphamide" (1 trials), "Doxorubicine + docetaxel sequential" (1 trials), "Insulin Glargine" (1 trials), "docetaxel, doxorubicin, cyclophosphamide" (1 trials) and "doxorubicine + cyclophosphamide combined" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sanofi-Aventis
The vast majority of trials in "Sanofi-Aventis" are
2 trials for "Female" genders and 1 trials for "All" genders.
Clinical Trials Status at Sanofi-Aventis
Currently, there are NaN active trials in "Sanofi-Aventis".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Sanofi-Aventis,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Sanofi-Aventis, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".